Skip to main content

Table 6 Lifetime costs (US$), effectiveness and ICERs in alternative scenario

From: The cost-effectiveness of Antiretroviral Treatment in Khayelitsha, South Africa – a primary data analysis

Treatment option

Lifetime costs

Outcomes

ICER

  

Life Years

QALYs

Life Years

QALYs

Undiscounted

Generalized No-ART

1,813

2.3

1.6

  

Generalized ART

9,474

9.7

8.1

1,035

1,184

Discounted

Generalized No-ART

1,706

2.1

1.5

  

Generalized ART

7,215

7.6

6.3

1,016

1,148